SANDS CAPITAL MANAGEMENT, LLC 13D and 13G filings for Ultragenyx Pharmaceutical Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 11:42 am Purchase | 2024-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE | SANDS CAPITAL MANAGEMENT, LLC | 4,298,003 4.700% | 179,995 (+4.37%) | Filing |
| 2024-02-13 3:41 pm Purchase | 2023-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE | SANDS CAPITAL MANAGEMENT, LLC | 4,118,008 5.000% | 4,118,008 (New Position) | Filing |